Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Mazabraud Yann sold 57,000 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Mazabraud Yann (EVP, Head of International) sold 57,000 Rhythm Pharmaceuticals, Inc. shares at an average US$116.15 for US$6.62M under a trading plan, leaving 55,655 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 57,000 shares
- Price
- US$116.15 average (US$111.80 to US$117.47)
- Value
- US$6.62M
- Holding after
- 55,655 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Head of International
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 46,625 | US$6.80 | 112,655 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 2,300 | US$111.80 | 110,355 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 1,000 | US$112.86 | 109,355 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 3,605 | US$114.70 | 105,750 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 14,568 | US$115.43 | 91,182 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 18,208 | US$116.49 | 72,974 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 17,319 | US$117.47 | 55,655 | Direct |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Mazabraud Yann
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Mazabraud Yann · Apr 3, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026